000 01253 a2200337 4500
005 20250512061504.0
264 0 _c19870528
008 198705s 0 0 eng d
022 _a0006-291X
024 7 _a10.1016/s0006-291x(87)80518-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChesney, C M
245 0 0 _aTriazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cApr 1987
300 _a359-66 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlprazolam
_xmetabolism
650 0 4 _aBinding, Competitive
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aDiazepam
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aKinetics
650 0 4 _aPlatelet Activating Factor
_xmetabolism
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aTriazolam
_xmetabolism
700 1 _aPifer, D D
700 1 _aCagen, L M
773 0 _tBiochemical and biophysical research communications
_gvol. 144
_gno. 1
_gp. 359-66
856 4 0 _uhttps://doi.org/10.1016/s0006-291x(87)80518-1
_zAvailable from publisher's website
999 _c3585627
_d3585627